|
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
|
||
|
|
|
Item 1.02.
|
Termination of a Material Definitive Agreement.
|
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Item 5.07. | Submission of Matters to a Vote of Security Holders. |
(1)
|
Shareholders elected the individuals named below to serve as Class I directors of the Company, to hold office until the annual general meeting of shareholders following the fiscal year ending March 31, 2025 and
until their successors are duly elected and qualified, or until such director’s earlier death, resignation or removal. Election of each director required approval by a plurality of the votes cast.
|
Nominee
|
For
|
Withheld
|
Broker Non-Votes
|
||
Matthew Gline
|
486,623,678
|
104,343,793
|
40,400,711
|
||
Dr. Keith Manchester
|
486,153,734
|
104,813,737
|
40,400,711
|
||
Melissa Epperly
|
589,710,901
|
1,256,570
|
40,400,711
|
(2)
|
Shareholders ratified the appointment of Ernst & Young LLP (“EY”) to serve as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2023 and to appoint EY as the
Company’s auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for the fiscal year ending March 31, 2023. Ratification required a simple majority of the votes cast.
|
For
|
630,953,276
|
||
Against
|
23,607
|
||
Abstain
|
391,299
|
Item 9.01.
|
Financial Statements and Exhibits.
|
Exhibit No.
|
|
Description of Exhibit
|
104
|
Cover Page Interactive Data File (embedded with Inline XBRL document)
|
ROIVANT SCIENCES LTD.
|
||
By:
|
/s/ Matt Maisak
|
|
Name: Matt Maisak
|
||
Title: Authorized Signatory
|